Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
19.9M
-
Shares change
-
-12.3M
-
Total reported value, excl. options
-
$88.5M
-
Value change
-
-$123M
-
Put/Call ratio
-
0.57
-
Number of buys
-
38
-
Number of sells
-
-31
-
Price
-
$4.45
Significant Holders of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) as of Q4 2019
92 filings reported holding SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share as of Q4 2019.
Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.9M shares
of 79.2M outstanding shares and own 25.1% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.57M shares), Bain Capital Life Sciences Investors, LLC (3.87M shares), BlackRock Inc. (1.92M shares), Artal Group S.A. (1.8M shares), MILLENNIUM MANAGEMENT LLC (1.13M shares), BOXER CAPITAL, LLC (1.03M shares), VANGUARD GROUP INC (862K shares), MORGAN STANLEY (694K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (421K shares), and STATE STREET CORP (348K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.